MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Create the #1 medical social network (Video/Pictures)
Global aggregator of choice for advanced medical technology business intelligence
Innovation & Royalty Aggregator
Royalty Pharma plc (NASDAQ:RPRX)
Finance & Acquisitions: Royalty Pharma
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO)*
Finance & Acquisition: Agios
Parents
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO)*
Children
*Agios has now raised, through alliances and investments, more than $163 million in less than two years (2010)
*Agios Pharmaceuticals Stock Quote: AGIO Stock News, Quotes, Analysis
*Agios Pharmaceuticals_Crunchbase
*Agios Pharmaceuticals, www.nasdaq.com
*Gross IPO Proceeds (2013):Agios-AGIO=$121.2 million
*Revenue: 14.24 million USD
2010: Celgene Pumps $130M Upfront into Agios Pharma for Drugs that Starve Cancer Cells (2010)
2011: Agios Pharmaceuticals Secures $78 Million Series C (2011)
2011: Agios Pulls in $20M From Celgene, Under Extended Cancer Metabolism Partnership (2011)
2020: Agios pivots away from oncology, auctioning off cancer pipeline for $2B and shifting the spotlight in restructuring
2020: Agios sells cancer business to French drug maker Servier for up to $2 billion
2022: Agios Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call Presentation_ seekingalpha.com
2024: Agios Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation
2025: Agios Pharmaceuticals, Inc. 2024 Q4 - Results - Earnings Call Presentation
Agios previously raised $33 million in a Series A round of funding from Boston-area firms Third Rock Ventures and Flagship Ventures, as well as Arch Venture Partners
Jumps
*Key People: Agios
Organization & Developments: Agios